🇺🇸 FDA
Pipeline program

Resveratrol

XJTU1AFCT-2016-007

Approved small_molecule active

Quick answer

Resveratrol for Pancreatitis, Acute is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Pancreatitis, Acute
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials